Compare PTGX & ORLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | ORLA |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.1B |
| IPO Year | 2016 | 2016 |
| Metric | PTGX | ORLA |
|---|---|---|
| Price | $92.39 | $18.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $100.17 | $27.00 |
| AVG Volume (30 Days) | 489.3K | ★ 1.8M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $711.26 | $199.20 |
| Revenue Next Year | N/A | $44.22 |
| P/E Ratio | ★ N/A | $107.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.60 | $7.02 |
| 52 Week High | $96.54 | $21.98 |
| Indicator | PTGX | ORLA |
|---|---|---|
| Relative Strength Index (RSI) | 60.15 | 49.10 |
| Support Level | $76.63 | $9.82 |
| Resistance Level | $92.05 | $20.05 |
| Average True Range (ATR) | 3.87 | 1.13 |
| MACD | 0.79 | -0.16 |
| Stochastic Oscillator | 80.77 | 32.93 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.